APITOPE

apitope-logo

Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Gravesโ€™ disease, Factor VIII intolerance and uveitis. The company, whose first product candidate is licensed to Merck Serono, will now progress its remaining portfolio of product candidates developed with its proprietary platform technology.

#SimilarOrganizations #People #Financial #Website #More

APITOPE

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2002-01-01

Address:
Bristol, Bristol, City Of, United Kingdom

Country:
United Kingdom

Website Url:
http://www.apitope.com

Total Employee:
11+

Status:
Active

Total Funding:
26.45 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

aerogen-logo

Aerogen

Aerogen is a medical device and drug delivery company.

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

immunos-therapeutics-logo

ImmunOs Therapeutics

ImmunOs Therapeutics is a clinical-stage biotechnology company.

neumora-therapeutics-logo

Neumora Therapeutics

Neumora Therapeutics operates as a clinical-stage biotechnology company.

Current Employees Featured

david-wraith_image

David Wraith
David Wraith Chief Scientific Officer & Founder @ Apitope
Chief Scientific Officer & Founder

keith-f-martin_image

Keith F Martin
Keith F Martin Chief Executive Officer @ Apitope
Chief Executive Officer

Founder


david-wraith_image

David Wraith

Investors List

limburgse-reconversie-maatschappij_image

Limburgse Reconversie Maatschappij

Limburgse Reconversie Maatschappij investment in Series B - Apitope

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series B - Apitope

pmv-pharmaceutcals-inc_image

PMV Pharmaceuticals

PMV Pharmaceuticals investment in Series B - Apitope

wyvern-seed-fund_image

Wyvern Seed Fund

Wyvern Seed Fund investment in Series B - Apitope

arthurian-life_image

Arthurian Life Sciences

Arthurian Life Sciences investment in Series B - Apitope

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series A - Apitope

vinnof_image

Vinnof

Vinnof investment in Series A - Apitope

Official Site Inspections

http://www.apitope.com Semrush global rank: 6.53 M Semrush visits lastest month: 954

  • Host name: 176-58-126-104.ip.linodeusercontent.com
  • IP address: 176.58.126.104
  • Location: London United Kingdom
  • Latitude: 51.5164
  • Longitude: -0.093
  • Timezone: Europe/London
  • Postal: EC2V

Loading ...

More informations about "Apitope" on Search Engine